OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab, Haitham Salah Eldin, Mohamed Taeimah, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1565

Showing 1-25 of 1565 citing articles:

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1237

COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925

Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
Ivana Djuričić, Philip C. Calder
Nutrients (2021) Vol. 13, Iss. 7, pp. 2421-2421
Open Access | Times Cited: 622

Organ-specific manifestations of COVID-19 infection
Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, et al.
Clinical and Experimental Medicine (2020) Vol. 20, Iss. 4, pp. 493-506
Open Access | Times Cited: 470

The SARS-CoV-2 as an instrumental trigger of autoimmunity
Arad Dotan, Sylviane Muller, Darja Kanduc, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 4, pp. 102792-102792
Open Access | Times Cited: 447

COVID-19 infection: an overview on cytokine storm and related interventions
Soheila Montazersaheb, Seyed Mahdi Hosseiniyan Khatibi, Mohammad Saeid Hejazi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 441

The COVID-19 pandemic: a global health crisis
Casey Pollard, Michael P. Morran, Andrea L. Nestor‐Kalinoski
Physiological Genomics (2020) Vol. 52, Iss. 11, pp. 549-557
Open Access | Times Cited: 432

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
Olivier Renaud‐Charest, Leanna M.W. Lui, Sherry Eskander, et al.
Journal of Psychiatric Research (2021) Vol. 144, pp. 129-137
Open Access | Times Cited: 323

Impact of the COVID‐19 Pandemic on Parent, Child, and Family Functioning
Mark E. Feinberg, Jacqueline Mogle, Jin‐Kyung Lee, et al.
Family Process (2021) Vol. 61, Iss. 1, pp. 361-374
Open Access | Times Cited: 307

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto, Julys da Fonseca Palmeira, Gustavo Adolfo Argañaraz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 238

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
Alexander Markov, Lakshmi Thangavelu, A. Surendar, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 226

Dietary Supplements during COVID-19 Outbreak. Results of Google Trends Analysis Supported by PLifeCOVID-19 Online Studies
Jadwiga Hamułka, Marta Jeruszka-Bielak, Magdalena Górnicka, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 54-54
Open Access | Times Cited: 214

Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
Lindsay T. McDonald
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 2, pp. L257-L265
Open Access | Times Cited: 211

T‐cell responses and therapies against SARS‐CoV‐2 infection
Salman M. Toor, Reem Saleh, Varun Sasidharan Nair, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 30-43
Open Access | Times Cited: 196

The effects of the COVID-19 pandemic on people with dementia
Katya Numbers, Henry Brodaty
Nature Reviews Neurology (2021) Vol. 17, Iss. 2, pp. 69-70
Open Access | Times Cited: 189

One year update on the COVID-19 pandemic: Where are we now?
Sanjay Kumar Mishra, Timir Tripathi
Acta Tropica (2020) Vol. 214, pp. 105778-105778
Open Access | Times Cited: 186

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
SangJoon Lee, Rudragouda Channappanavar, Thirumala‐Devi Kanneganti
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1083-1099
Open Access | Times Cited: 185

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 185

Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
Liyuan Cao, Wei Mu
Pharmacological Research (2020) Vol. 163, pp. 105297-105297
Open Access | Times Cited: 180

Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
Miguel Alejandro Pinzón, Santiago Ortiz, Héctor Holguín, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252057-e0252057
Open Access | Times Cited: 178

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
Sujan Dhar, K. Vishnupriyan, Sharat Damodar, et al.
Heliyon (2021) Vol. 7, Iss. 2, pp. e06155-e06155
Open Access | Times Cited: 177

COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 174

Comparative ACE2 variation and primate COVID-19 risk
Amanda Melin, Mareike C. Janiak, Frank Marrone, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 167

Page 1 - Next Page

Scroll to top